Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy

RemeGen Co., Ltd. · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
gastric-cancer
gastric cancer, gastroesophageal junction adenocarcinoma, her2- expressing, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 862849
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.